OSR Health Warrant
OSRHW
16 hedge funds and large institutions have $7.52M invested in OSR Health Warrant in 2023 Q1 according to their latest regulatory filings, with 16 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
+$28.9K |
| 2 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$25.1K |
| 3 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$22.7K |
| 4 |
ASM
ATW SPAC Management
New York
|
+$21.7K |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$21.7K |
Top Sellers
OSRHW Hedge Fund Activity: Q1 2023 in Review
16 of the 6,277 institutional investors tracked by Wall St. Rank reported a position in OSR Health Warrant (OSRHW) for Q1 2023, worth a combined $7.52M.
Buyers outnumbered sellers: 16 funds opened new OSRHW positions and 0 closed out — a net gain of 16 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Mangrove Partners, opening a new position worth an estimated $28.9K.
- 16 institutional investors held OSR Health Warrant (OSRHW) as of Q1 2023, up from 0 in Q4 2022.
- Funds reported $7.52M of OSR Health Warrant stock for Q1 2023.
- 16 funds opened new OSR Health Warrant positions in Q1 2023 and 0 closed out, a net change of +16 holders.
- The largest OSR Health Warrant buyer in Q1 2023 was Mangrove Partners, an estimated $28.9K added.
Based on aggregated 13F filings for Q1 2023.